Back to discover
Drug

Miconazole

Established medicine
ClassCytochrome P450 51 inhibitorResearchOngoing clinical research
Also known as Aloe Vesta, Aloe Vesta 2 in 1 Antifungal, Aloe Vesta Antifungal, Anti-Fungal+45 more

Aloe Vesta, Aloe Vesta 2 in 1 Antifungal, Aloe Vesta Antifungal, Anti-Fungal, Baza, Baza Antifungal, Critic-Aid Clear, Cruex Prescription Strength, DermaFungal, Dermagran, Desenex, Femmesil, Fungizyl, Fungoid, Hongo Killer Ultra, Inzo, Lagicam, Lasolex, MacerRx, Malaseb, Micaderm, Micatin, Micatin Foot Powder Deodorant, MiconaHex+Triz, Miconazole Nitrate, Micro-Guard, Mitrazol, Monistat, Monistat 7, NuZole, ORAVIG, Ony-Clear, Prescription Strength Cruex, Rash Relief Antifungal, Secura, Silka Powder, Surolan, Tetterine, Ting AF, Triple Paste AF, Vagistat, Vusion, Yeast-X Int, Zeasorb, Conazol Miconazole, Fungoid (Miconazole), Miconazol, 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole, Miconazolum.

Lanosterol 14-alpha demethylase
Primary target
1
Regulatory events

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Miconazole
Aliases & brands
Aloe VestaAloe Vesta 2 in 1 AntifungalAloe Vesta AntifungalAnti-FungalBazaBaza AntifungalCritic-Aid ClearCruex Prescription StrengthDermaFungalDermagranDesenexFemmesilFungizylFungoidHongo Killer UltraInzoLagicamLasolexMacerRxMalasebMicadermMicatinMicatin Foot Powder DeodorantMiconaHex+TrizMiconazole NitrateMicro-GuardMitrazolMonistatMonistat 7NuZoleORAVIGOny-ClearPrescription Strength CruexRash Relief AntifungalSecuraSilka PowderSurolanTetterineTing AFTriple Paste AFVagistatVusionYeast-X IntZeasorbConazol MiconazoleFungoid (Miconazole)Miconazol1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazoleMiconazolum
RxNorm CUI
6932
ChEMBL ID
CHEMBL91
ATC codes
G01AF04S02AA13J02AB01A01AB09D01AC52A07AC01D01AC02
UNII
7NNO0D7S5M
Primary mechanism
Cytochrome P450 51 inhibitor
Regulatory jurisdictions
mhra

Pharmacology & targets

1 target

Known molecular targets and mechanisms supported by curated pharmacology databases.

INHIBITORCytochrome P450 51 inhibitor

Regulatory timeline

1 event

The complete regulatory record, grouped by authority — approvals, safety advisories and label changes. Each authority shows its most recent events; expand one to read its full history.

Authorities
MHRA
Total events
1
mhraMedicines and Healthcare products Regulatory Agency· 1 event
2017-09-26Safety communicationSafety
Drug Safety Update: Miconazole (Daktarin): over-the-counter oral gel contraindicated in patients taking warfarin
Evidence ↗

Contains public sector information from the Medicines and Healthcare products Regulatory Agency (MHRA) licensed under the Open Government Licence (OGL v3).

Clinical trials

6 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
6
registered trials across all phases
LATEST COMPLETION 2016
4
Late-stage (III+)
4
Completed
2
Discontinued
PHASE DISTRIBUTIONn = 6
Phase 11Phase 21Phase 31Phase 43

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • ClinicalTrials.gov — clinical trials
  • Regulatory event sources are credited in the Regulatory Timeline above.